{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T13:09:43Z","timestamp":1777468183169,"version":"3.51.4"},"reference-count":57,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2008,4,1]],"date-time":"2008-04-01T00:00:00Z","timestamp":1207008000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"published-print":{"date-parts":[[2008,4]]},"DOI":"10.1016\/j.pnpbp.2007.12.017","type":"journal-article","created":{"date-parts":[[2008,1,30]],"date-time":"2008-01-30T14:59:32Z","timestamp":1201705172000},"page":"835-843","source":"Crossref","is-referenced-by-count":27,"title":["Tiagabine, a GABA uptake inhibitor, attenuates 3-nitropropionic acid-induced alterations in various behavioral and biochemical parameters in rats"],"prefix":"10.1016","volume":"32","author":[{"given":"Ashish","family":"Dhir","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kiran Kumar","family":"Akula","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.K.","family":"Kulkarni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.pnpbp.2007.12.017_bib1","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1111\/j.1472-8206.2007.00540.x","article-title":"Systemic administration of adenosine ameliorates pentylenetetrazol (PTZ)-induced chemical kindling and secondary behavioral and biochemical changes in mice","volume":"21","author":"Akula","year":"2007","journal-title":"Fundam Clin Pharmacol"},{"key":"10.1016\/j.pnpbp.2007.12.017_bib2","doi-asserted-by":"crossref","first-page":"2353","DOI":"10.1093\/brain\/122.12.2353","article-title":"Huntington's disease progression. PET and clinical observations","volume":"122","author":"Andrews","year":"1999","journal-title":"Brain"},{"key":"10.1016\/j.pnpbp.2007.12.017_bib3","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0306-4522(97)00266-2","article-title":"Glial cell line-derived neurotrophic factor attenuates the locomotor hypofunction and striatonigral neurochemical deficits induced by chronic systemic administration of the mitochondrial toxin 3-nitropropionic acid","volume":"82","author":"Araujo","year":"1997","journal-title":"Neuroscience"},{"key":"10.1016\/j.pnpbp.2007.12.017_bib4","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1111\/1467-9450.00238","article-title":"Dopamine and cognitive functioning: brain imaging findings in Huntington's disease and normal aging","volume":"42","author":"Backman","year":"2001","journal-title":"Scand J Psychol"},{"key":"10.1016\/j.pnpbp.2007.12.017_bib5","doi-asserted-by":"crossref","first-page":"4181","DOI":"10.1523\/JNEUROSCI.13-10-04181.1993","article-title":"Neurochemical and histologic characterization of striatal excitotoxic lesions produced by the mitochondrial toxin 3-nitropropionic acid","volume":"13","author":"Beal","year":"1993","journal-title":"J Neurosci"},{"key":"10.1016\/j.pnpbp.2007.12.017_bib6","doi-asserted-by":"crossref","first-page":"2701","DOI":"10.2174\/138161206777698693","article-title":"Pharmacological management of Huntington's disease: an evidence-based review","volume":"12","author":"Bonelli","year":"2006","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.pnpbp.2007.12.017_bib7","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/0006-8993(95)00901-2","article-title":"Behavioral pathology induced by repeated systemic injections of 3-nitropropionic acid mimics the motoric symptoms of Huntington's disease","volume":"697","author":"Borlongan","year":"1995","journal-title":"Brain Res"},{"key":"10.1016\/j.pnpbp.2007.12.017_bib8","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/0361-9230(94)00242-S","article-title":"Systemic 3-nitropropionic acid: behavioral deficits and striatal damage in adult rats","volume":"36","author":"Borlongan","year":"1995","journal-title":"Brain Res Bull"},{"key":"10.1016\/j.pnpbp.2007.12.017_bib9","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/S0149-7634(96)00027-9","article-title":"3-Nitropropionic acid animal model and Huntington's disease","volume":"21","author":"Borlongan","year":"1997","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1016\/j.pnpbp.2007.12.017_bib10","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1111\/j.1471-4159.1990.tb01919.x","article-title":"(R)-N-[4,4-bis(3-methyl-2-thienyl)but-3-en-1-yl]nipecotic acid binds with high affinity to the brain gamma-amino butyric acid uptake carrier","volume":"54","author":"Braestrup","year":"1990","journal-title":"J Neurochem"},{"key":"10.1016\/j.pnpbp.2007.12.017_bib11","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0891-0618(99)00029-0","article-title":"Chemical and anatomical changes in the striatum and substantia nigra following quinolinic acid lesions in the striatum of the rat: a detailed time course of the cellular and GABA(A) receptor changes","volume":"17","author":"Brickell","year":"1999","journal-title":"J Chem Neuroanat"},{"key":"10.1016\/j.pnpbp.2007.12.017_bib12","doi-asserted-by":"crossref","first-page":"815","DOI":"10.2174\/0929867013373048","article-title":"Brain oxidative stress in animal models of accelerated aging and the age-related neurodegenerative disorders, Alzheimer's disease and Huntington's disease","volume":"8","author":"Butterfield","year":"2001","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.pnpbp.2007.12.017_bib13","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.jns.2005.03.012","article-title":"Oxidative stress, mitochondrial dysfunction and cellular stress response in Friedreich's ataxia","volume":"233","author":"Calabrese","year":"2005","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.pnpbp.2007.12.017_bib14","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/BF02335845","article-title":"Effects of DA agonist in Huntington disease hyperkinesia","volume":"1","author":"Caraceni","year":"1980","journal-title":"Ital J Neurol Sci"},{"key":"10.1016\/j.pnpbp.2007.12.017_bib15","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0304-3940(00)01206-4","article-title":"Biological effects of tiagabine on primary cortical astrocyte cultures of rat","volume":"288","author":"Cardile","year":"2000","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.pnpbp.2007.12.017_bib16","doi-asserted-by":"crossref","first-page":"6480","DOI":"10.1073\/pnas.95.11.6480","article-title":"Altered brain neurotransmitter receptors in transgenic mice expressing a portion of an abnormal human Huntington disease gene","volume":"95","author":"Cha","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.pnpbp.2007.12.017_bib17","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.bbrc.2007.05.093","article-title":"Increased oxidative damage and mitochondrial abnormalities in the peripheral blood of Huntington's disease patients","volume":"359","author":"Chen","year":"2007","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.pnpbp.2007.12.017_bib18","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0070-2153(06)75002-5","article-title":"Selective neuronal degeneration in Huntington's disease","volume":"75","author":"Cowan","year":"2006","journal-title":"Curr Top Dev Biol"},{"key":"10.1016\/j.pnpbp.2007.12.017_bib19","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1016\/S0028-3908(00)00075-7","article-title":"GABA-level increasing and anticonvulsant effects of three different GABA uptake inhibitors","volume":"39","author":"Dalby","year":"2000","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pnpbp.2007.12.017_bib20","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1111\/j.1471-4159.2005.03588.x","article-title":"Selective deficits in the expression of striatal-enriched mRNAs in Huntington's disease","volume":"96","author":"Desplats","year":"2006","journal-title":"J Neurochem"},{"key":"10.1016\/j.pnpbp.2007.12.017_bib21","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1007\/s10787-006-1535-3","article-title":"Rofecoxib, a selective cyclooxygenase-2 (COX-2) inhibitor potentiates the anticonvulsant activity of tiagabine against pentylenetetrazol-induced convulsions in mice","volume":"14","author":"Dhir","year":"2006","journal-title":"Inflammopharmacology"},{"key":"10.1016\/j.pnpbp.2007.12.017_bib22","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1111\/j.1440-1681.2005.04233.x","article-title":"Effect of naproxen, a non-selective cyclo-oxygenase inhibitor, on pentylenetetrazol-induced kindling in mice","volume":"32","author":"Dhir","year":"2005","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"10.1016\/j.pnpbp.2007.12.017_bib23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1006\/exnr.2000.7434","article-title":"Participation of par-4 in the degeneration of striatal neurons induced by metabolic compromise with 3-nitropropionic acid","volume":"165","author":"Duan","year":"2000","journal-title":"Exp Neurol"},{"key":"10.1016\/j.pnpbp.2007.12.017_bib24","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/0003-9861(59)90090-6","article-title":"Tissue sulfhydryl groups","volume":"82","author":"Ellman","year":"1959","journal-title":"Arch Biochem Biophys"},{"key":"10.1016\/j.pnpbp.2007.12.017_bib25","series-title":"Amino acids: chemistry, biology and medicine","first-page":"263","article-title":"Blockade of audiogenic seizures by a GABA-uptake inhibitor, NO-328, in the genetically epilepsy-prone rat","author":"Faingold","year":"1990"},{"key":"10.1016\/j.pnpbp.2007.12.017_bib26","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/S0197-4580(01)00300-1","article-title":"Phenolic anti-inflammatory antioxidant reversal of Abeta-induced cognitive deficits and neuropathology","volume":"22","author":"Frautschy","year":"2001","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.pnpbp.2007.12.017_bib27","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/0003-2697(82)90118-X","article-title":"Analysis of nitrate, nitrite, and [15 N] nitrate in biological fluids","volume":"126","author":"Green","year":"1982","journal-title":"Anal Biochem"},{"key":"10.1016\/j.pnpbp.2007.12.017_bib28","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1093\/jn\/117.9.1570","article-title":"Uptake and release of adrenal ascorbic acid in the guinea pig after injection of ACTH","volume":"117","author":"Kipp","year":"1987","journal-title":"J Nutr"},{"key":"10.1016\/j.pnpbp.2007.12.017_bib29","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/0006-8993(94)90085-X","article-title":"Systemic 3-nitropropionic acid: long-term effects on locomotor behavior","volume":"646","author":"Koutouzis","year":"1994","journal-title":"Brain Res"},{"key":"10.1016\/j.pnpbp.2007.12.017_bib30","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1097\/00008877-200609000-00014","article-title":"Effect of resveratrol on 3-nitropropionic acid-induced biochemical and behavioural changes: possible neuroprotective mechanisms","volume":"17","author":"Kumar","year":"2006","journal-title":"Behav Pharmacol"},{"key":"10.1016\/j.pnpbp.2007.12.017_bib31","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1111\/j.1472-8206.2007.00485.x","article-title":"Cyclooxygenase inhibition attenuates 3-nitropropionic acid-induced neurotoxicity in rats: possible antioxidant mechanisms","volume":"21","author":"Kumar","year":"2007","journal-title":"Fundam Clin Pharmacol"},{"key":"10.1016\/j.pnpbp.2007.12.017_bib32","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/S0006-8993(00)01948-X","article-title":"3-Nitropropionic acid induced in vivo protein oxidation in striatal and cortical synaptosomes: insights into Huntington's disease","volume":"858","author":"La Fontaine","year":"2000","journal-title":"Brain Res"},{"key":"10.1016\/j.pnpbp.2007.12.017_bib33","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1159\/000177573","article-title":"Plasma cortisol and adrenal ascorbic acid levels after ACTH treatment with a high intake of ascorbic acid in the guinea pig","volume":"34","author":"Laney","year":"1990","journal-title":"Ann Nutr Metab"},{"key":"10.1016\/j.pnpbp.2007.12.017_bib34","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.pneurobio.2004.02.002","article-title":"Magnetic resonance imaging and spectroscopy in assessing 3-nitropropionic acid-induced brain lesions: an animal model of Huntington's disease","volume":"72","author":"Lee","year":"2004","journal-title":"Prog Neurobiol"},{"key":"10.1016\/j.pnpbp.2007.12.017_bib35","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1602\/neurorx.1.1.128","article-title":"The paradigm of Huntington's disease: therapeutic opportunities in neurodegeneration","volume":"1","author":"Leegwater-Kim","year":"2004","journal-title":"NeuroRX"},{"key":"10.1016\/j.pnpbp.2007.12.017_bib36","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0021-9258(19)52451-6","article-title":"Protein measurement with the folin-phenol reagent","volume":"193","author":"Lowry","year":"1951","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pnpbp.2007.12.017_bib37","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1159\/000122564","article-title":"Effect of gamma aminobutyric acid (GABA) and GABA antagonist drugs on ACTH release","volume":"16","author":"Makara","year":"1974","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.pnpbp.2007.12.017_bib38","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1006\/exnr.1997.6522","article-title":"3-Nitropropionic acid neurotoxicity: visualization by silver staining and implications for use as an animal model of Huntington's disease","volume":"146","author":"Miller","year":"1997","journal-title":"Exp Neurol"},{"key":"10.1016\/j.pnpbp.2007.12.017_bib39","first-page":"114","article-title":"The determination of nucleic acids","volume":"vol. 14","author":"Monro","year":"1966"},{"key":"10.1016\/j.pnpbp.2007.12.017_bib40","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/0014-2999(91)90438-V","article-title":"Characterization of Tiagabine (NO-328), a new potent and selective GABA uptake inhibitor","volume":"196","author":"Nielsen","year":"1991","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pnpbp.2007.12.017_bib41","doi-asserted-by":"crossref","first-page":"29","DOI":"10.2165\/00003088-199631010-00003","article-title":"The clinical pharmacokinetics of the newer antiepileptic drugs. Focus on topiramate, zonisamide and tiagabine","volume":"31","author":"Perucca","year":"1996","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.pnpbp.2007.12.017_bib42","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0304-3940(02)01193-X","article-title":"Neuroprotective effects of anticonvulsants in rat hippocampal slice cultures exposed to oxygen\/glucose deprivation","volume":"335","author":"Rekling","year":"2003","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.pnpbp.2007.12.017_bib43","doi-asserted-by":"crossref","first-page":"10116","DOI":"10.1523\/JNEUROSCI.18-23-10116.1998","article-title":"Dopamine modulates the susceptibility of striatal neurons to 3-nitropropionic acid in the rat model of Huntington's disease","volume":"18","author":"Reynolds","year":"1998","journal-title":"J Neurosci"},{"key":"10.1016\/j.pnpbp.2007.12.017_bib44","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/S0021-9258(18)72395-8","article-title":"The determination of ascorbic acid in whole blood and urine through the 2, 4-dinitrophenyl hydrazine derivative of dehydro ascorbic acid","volume":"147","author":"Roe","year":"1943","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pnpbp.2007.12.017_bib45","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.mcn.2003.09.013","article-title":"Neuronal vulnerability following inhibition of mitochondrial complex II: a possible ionic mechanism for Huntington's disease","volume":"25","author":"Saulle","year":"2004","journal-title":"Mol Cell Neurosci"},{"key":"10.1016\/j.pnpbp.2007.12.017_bib46","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/0197-0186(95)00122-0","article-title":"Involvement of oxidative stress in 3-nitropropionic acid neurotoxicity","volume":"29","author":"Schulz","year":"1996","journal-title":"Neurochem Int"},{"key":"10.1016\/j.pnpbp.2007.12.017_bib47","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1023\/A:1006852306789","article-title":"The role of mitochondrial dysfunction and neuronal nitric oxide in animal models of neurodegenerative diseases","volume":"174","author":"Schulz","year":"1997","journal-title":"Mol Cell Biochem"},{"key":"10.1016\/j.pnpbp.2007.12.017_bib48","doi-asserted-by":"crossref","first-page":"779S","DOI":"10.1002\/j.1550-8528.1995.tb00499.x","article-title":"Chronically administered 3-nitropropionic acid produces selective lesions in the striatum and reduces muscle tonus","volume":"3","author":"Shimano","year":"1995","journal-title":"Obes Res"},{"key":"10.1016\/j.pnpbp.2007.12.017_bib49","first-page":"882","article-title":"Role of adenosine in drug-induced catatonia in mice","volume":"40","author":"Singh","year":"2002","journal-title":"Indian J Exp Biol"},{"key":"10.1016\/j.pnpbp.2007.12.017_bib50","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1111\/j.1528-1157.1995.tb02576.x","article-title":"A review of the preclinical pharmacology of tiagabine: a potent and selective anticonvulsant GABA uptake inhibitor","volume":"36","author":"Suzdak","year":"1995","journal-title":"Epilepsia"},{"key":"10.1016\/j.pnpbp.2007.12.017_bib51","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.pbb.2005.10.018","article-title":"Neuroprotective effect of taurine in 3-nitropropionic acid-induced experimental animal model of Huntington's disease phenotype","volume":"82","author":"Tadros","year":"2005","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.pnpbp.2007.12.017_bib52","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1002\/jnr.21046","article-title":"Striatal specificity of gene expression dysregulation in Huntington's disease","volume":"84","author":"Thomas","year":"2006","journal-title":"J Neurosci Res"},{"key":"10.1016\/j.pnpbp.2007.12.017_bib53","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1016\/j.neuroscience.2006.10.056","article-title":"Oxidative stress and mitochondrial dysfunction in neurodegenerative diseases","volume":"145","author":"Trushina","year":"2007","journal-title":"Neuroscience"},{"key":"10.1016\/j.pnpbp.2007.12.017_bib54","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1046\/j.1365-2990.1999.00212.x","article-title":"3-Nitropropionic acid induces a spectrum of Huntington's disease-like neuropathology in rat striatum","volume":"25","author":"Vis","year":"1999","journal-title":"Neuropathol Appl Neurobiol"},{"key":"10.1016\/j.pnpbp.2007.12.017_bib55","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1002\/(SICI)1097-4547(19981101)54:3<301::AID-JNR1>3.0.CO;2-W","article-title":"Molecular aspects of Huntington's disease","volume":"54","author":"Walling","year":"1998","journal-title":"J Neurosci Res"},{"key":"10.1016\/j.pnpbp.2007.12.017_bib56","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1042\/bj0990667","article-title":"Mechanism of lipid peroxide formation in animal tissues","volume":"99","author":"Wills","year":"1966","journal-title":"J Biochem"},{"key":"10.1016\/j.pnpbp.2007.12.017_bib57","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1002\/da.10099","article-title":"Effects of tiagabine on cholecystokinin\u2013tetrapeptide (CCK-4)-induced anxiety in healthy volunteers","volume":"18","author":"Zwanzger","year":"2003","journal-title":"Depress Anxiety"}],"container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584607004484?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584607004484?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,9,3]],"date-time":"2021-09-03T01:23:14Z","timestamp":1630632194000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0278584607004484"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,4]]},"references-count":57,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008,4]]}},"alternative-id":["S0278584607004484"],"URL":"https:\/\/doi.org\/10.1016\/j.pnpbp.2007.12.017","relation":{},"ISSN":["0278-5846"],"issn-type":[{"value":"0278-5846","type":"print"}],"subject":[],"published":{"date-parts":[[2008,4]]}}}